N332-GT5 gp140 envelope trimer vaccine with SMNP adjuvant

HIV-1 envelope trimer N332-GT5 gp140 with SMNP adjuvant · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N332-GT5 gp140 envelope trimer vaccine with SMNP adjuvant, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV [Phase 1]

See pricing